Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cervical cancer
Biotech
Barinthus HPV drug doesn't prove efficacy
Barinthus' high risk human papillomavirus treatment is safe, but a phase 1 test failed to prove it actually works.
James Waldron
Apr 19, 2024 9:50am
Hologic harnesses FDA nod for AI-powered Pap test analysis
Feb 2, 2024 10:08am
BD taps Techcyte to bring AI to Pap smear tests
Jan 31, 2024 11:58am
Akeso's bispecific notches ph. 3 victory against gastric cancer
Nov 7, 2023 10:50am
Combo may offer route back for Agenus' cervical cancer drug
Jan 23, 2023 10:47am
Investors flip-flop on Nykode's cancer vaccine data drop
May 9, 2022 8:50am